Jazz Pharmaceuticals Plc (JAZZ) Return on Investment ROI from the third quarter of 2026 to third quarter of 2025 and for the year 2026, average high and low, overall ranking from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Jazz Pharmaceuticals Plc  (NASDAQ: JAZZ)


Jazz Pharmaceuticals Plc's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Jazz Pharmaceuticals Plc's ROI in the third quarter of 2026?
Jazz Pharmaceuticals Plc achieved a return on average invested assets (ROI) of 2.26 % in its third quarter of 2026, which is below Jazz Pharmaceuticals Plc's average return on investment, which stands at 8.3%.

ROI decreased relative to the period ending Jun 30 2026, due to the decline in net income.

Within the Healthcare sector 94 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Sep 30 2026 quarter, so far to 2474, from total ROI ranking in the second quarter of 2026 at 3283.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Investment Change TTM 1.12 % -7.98 % -12.79 % -9.44 % -2.03 %
Y / Y Net Income Change TTM - - -90.6 % - -
Investment (TTM) in Millions 9,761 9,153 8,857 8,647 8,291
Return On Investment (TTM) 2.26 % 10.77 % 0.35 % -4.13 % -4.09 %
JAZZ's Overall Ranking # 2474 # 3283 # 2908 # 2912 # 1354
Seq. Investment Change TTM 4.21 % 3.28 % -1.9 % -4.23 % -5.16 %
Seq. Net Income Change TTM -78.11 % 3089.78 % - - -
Net Income (TTM) in Millions 206 941 29 -356 -368

JAZZ Company Profile >> Back to JAZZ Roi Comparisons >> See Annual JAZZ Return On Investment



Return On Investment JAZZ's Ranking
Within: No.
Industry # 27
Sector # 95
Overall # 2474

Return On Investment Statistics
High Average Low
85.99 %
8.3 %
-4.1 %
(Dec 31 2011)   (Mar 31 2022)







Financial Statements
Jazz Pharmaceuticals Plc's III. Quarter Investments $ 9,761 Millions JAZZ's Balance sheet
Jazz Pharmaceuticals Plc's III. Quarter Income $ -483 Millions Quarterly JAZZ's Income Statement
JAZZ's Income by Division See JAZZ's Income by Division


JAZZ Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 8,647 10,171 8,845 8,779 11,489
Y / Y Investment Growth -14.99 % 15 % 0.75 % -23.59 % 95.33 %
Net Income in Millions -356 560 415 -224 -330
Y / Y Net Income Growth - 35.02 % - - -
Annual Return On Investment -4.12 % 5.51 % 4.69 % -2.55 % -2.87 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
JAZZ's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for JAZZ's Competitors
Subscribers only: Roi for Jazz Pharmaceuticals Plc's Suppliers
Subscribers only: Return On Investment for JAZZ's Customers

Other Ratios
JAZZ's Roa JAZZ's Inventory Turnover Ratio JAZZ's Growth Rates JAZZ's Dividend Statistics
JAZZ's Profitability Ratios JAZZ's Asset Turnover Ratio JAZZ's Dividend Growth
JAZZ's Roe JAZZ's Valuation Ratios JAZZ's Financial Strength Ratios JAZZ's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2026, within Healthcare Sector ROI
Merit Medical Systems Inc  6.21 %
Davita Inc   6.13 %
Black Hawk Acquisition Corporation  6.10 %
Iqvia Holdings Inc   6.09 %
Labcorp Holdings Inc   6.07 %
Pacs Group Inc   5.95 %
Ensign Group Inc  5.94 %
Amneal Pharmaceuticals Inc   5.59 %
Sotera Health Company  5.43 %
Henry Schein Inc   5.27 %
Abbott Laboratories  5.14 %
Haemonetics Corporation  4.85 %
Teleflex Incorporated  4.81 %
Lifestance Health Group Inc   3.71 %
U S Physical Therapy Inc  3.33 %
Conmed Corporation  3.16 %
Integer Holdings Corporation  3.13 %
Avantor Inc   3.11 %
Innovage Holding Corp   2.95 %
Ligand Pharmaceuticals Incorporated  2.84 %
Revvity Inc  2.35 %
Pfizer Inc  2.34 %
Jazz Pharmaceuticals Plc  2.12 %
Teva Pharmaceutical Industries Limited  1.96 %
Icu Medical Inc  1.74 %
Biogen Inc   1.26 %
Community Health Systems Inc   1.03 %
Waters Corporation  0.51 %

Date modified: 2026-11-03T10:00:43+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.